Evidence map›Paper›PMID 42260610›Full record

ArticleJournal of nanobiotechnology2026

Polygonatum polysaccharide microspheres encapsulated living Clostridium butyricum for mucosal barrier repair and immune regulation.

Qinglian Hu, Xiangchi Xu, Jing Feng, Jiyue Hu, Chaozhi Wei, Jintao Cheng, Yue Chen, Yuanxiang Jin

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qinglian HuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China.
Xiangchi XuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China.
Jing FengCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China.
Jiyue HuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China.
Chaozhi WeiXianghu Laboratory, Hangzhou, 310032, China.
Jintao ChengXianghu Laboratory, Hangzhou, 310032, China. jintaocheng@zju.edu.cn.
Yue ChenXianghu Laboratory, Hangzhou, 310032, China. earnchen@163.com.
Yuanxiang JinCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China. jinyx@zjut.edu.cn.

Funding

Key Scientific Research Projects of Xianghu Laboratory 2023C4S02002National Natural Science Foundation of China 42277279Zhejiang Provincial Natural Science Foundation of China No. LQN25C010005 and LY21E030011
6 · The paper itself

Abstract

A collaborative intervention strategy based on probiotics represents a promising therapeutic approach against inflammatory bowel disease (IBD). However, enhancing probiotic efficacy within the IBD microenvironment while minimizing side effects remains a critical challenge. Polygonatum polysaccharide (PP), a natural plant-derived bioactive polymer, has attracted significant attention due to its ability to regulate oxidative and inflammatory stress with a favorable safety profile. Herein, PP was incorporated into calcium-alginate microgels (Mgel), resulting in enhanced mechanical strength and thermal stability. Compared to conventional calcium-alginate microgels, the PP-loaded microgels exhibited improved performance in oral delivery. In addition, PP functions as a promising microenvironmental modulator, exhibiting broad-spectrum antioxidant, anti-inflammatory, and prebiotic properties. The microgel system provides a versatile platform for probiotic oral delivery, contributing to the reshaping of the IBD microenvironment by enhancing the efficacy of Clostridium butyricum JHP6 and increasing beneficial metabolite levels in colitis. Collectively, naturally derived polysaccharide-based microspheres encapsulating probiotics offer an effective strategy to modulate the IBD microenvironment and enhance probiotic efficacy, thereby representing a collaborative intervention approach for IBD.

Indexed as

Clostridium butyricumMicrospheresPolygonatumPolysaccharidesProbioticsAlginatesAnimalsAnti-Inflammatory AgentsAntioxidantsHexuronic AcidsHumansInflammatory Bowel DiseasesIntestinal Barrier FunctionIntestinal MucosaMiceAlginatesAnti-Inflammatory AgentsAntioxidantsHexuronic AcidsPolysaccharidesClostridium butyricumInflammatory bowel diseaseMicrospheresMitochondrial dysfunctionPolygonatum polysaccharide

Identifiers

PMID42260610
PMCPMC13471405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.